Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: CYP2E1 genetic polymorphisms and risk of nasopharyngeal carcinoma in Taiwan.
Authors: Hildesheim A,  Anderson LM,  Chen CJ,  Cheng YJ,  Brinton LA,  Daly AK,  Reed CD,  Chen IH,  Caporaso NE,  Hsu MM,  Chen JY,  Idle JR,  Hoover RN,  Yang CS,  Chhabra SK
Journal: J Natl Cancer Inst
Date: 1997 Aug 20
Branches: EBP, ITEB, MEB
PubMed ID: 9274915
PMC ID: not available
Abstract: BACKGROUND: Nasopharyngeal carcinoma occurs disproportionately among individuals of Chinese descent. The cytochrome P450 2E1 enzyme (CYP2E1) is known to activate nitrosamines and other carcinogens that are possibly involved in the development of this disease. Certain alleles of the CYP2E1 gene are thought to be more highly expressed than others, and their distribution varies between Asian and Caucasian populations. We conducted a case-control study to investigate whether such variations affect the risk of developing nasopharyngeal cancer. METHODS: Three hundred sixty-four patients with nasopharyngeal carcinoma (96% of 378 eligible patients) and 320 control subjects (86% of 374 eligible subjects) were studied. A risk factor questionnaire was administered to participants to assess factors postulated to be linked to nasopharyngeal carcinoma. Peripheral blood was obtained from all subjects and DNA was purified from nucleated cells. A polymerase chain reaction-based restriction fragment length polymorphism assay that used the restriction enzymes Rsa I and Dra I was used to detect wild-type and variant forms of the CYP2E1 gene. RESULTS: Individuals homozygous for an allele of the CYP2E1 gene that is detected by Rsa I digestion (c2 allele) were found to have an increased risk of nasopharyngeal carcinoma (relative risk [RR] = 2.6; 95% confidence interval [CI] = 1.2-5.7); this effect was limited to nonsmokers (RR = 9.3; 95% CI = 2.7-32) and was not affected by alcohol consumption. CONCLUSIONS: Our findings suggest that the CYP2E1 genotype is a determinant of nasopharyngeal carcinoma risk.